Company / Operating Cash Flow per Share
Zoetis Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$6.48
FY2025
5-year range
$3.78 / $6.48
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#19 of 212
Health Care
What the data says
Among 212 Health Care companies, Zoetis is in the top 9% for operating cash flow per share. Operating Cash Flow per Share has increased for 9 consecutive years, from $1.26 in FY2016 to $6.48 in FY2025.
Based on SEC 10-K filings.
6.48 in FY2025 with a 5-year CAGR of +11.5%. Top quartile in the Health Care sector.
Improved from $4.77 to $6.48 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
+144.0% above sector average
Key checks
Key Insights
- Zoetis's operating cash flow per share has grown for 9 consecutive years.
- In FY2025, operating cash flow per share increased 0.5% year-over-year.
- Ranks #19 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.48 | +0.5% |
| FY2024 | $6.44 | +35.0% |
| FY2023 | $4.77 | +6.1% |
| FY2022 | $4.50 | +19.1% |
| FY2021 | $3.78 | +0.3% |
| FY2020 | $3.76 | +0.6% |
| FY2019 | $3.74 | +1.7% |
| FY2018 | $3.68 | +173.3% |
| FY2017 | $1.35 | +7.0% |
| FY2016 | $1.26 | -7.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026